Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Cell Commun Signal ; 16(1): 66, 2018 10 11.
Artículo en Inglés | MEDLINE | ID: mdl-30305100

RESUMEN

BACKGROUND: By allowing intercellular communication between cells, tunneling nanotubes (TNTs) could play critical role in cancer progression. If TNT formation is known to require cytoskeleton remodeling, key mechanism controlling their formation remains poorly understood. METHODS: The cells of human bronchial (HBEC-3, A549) or mesothelial (H2452, H28) lines are transfected with different siRNAs (inactive, anti-RASSF1A, anti-GEFH1 and / or anti-Rab11). At 48 h post-transfection, i) the number and length of the nanotubes per cell are quantified, ii) the organelles, previously labeled with specific tracers, exchanged via these structures are monitored in real time between cells cultured in 2D or 3D and in normoxia, hypoxia or in serum deprivation condition. RESULTS: We report that RASSF1A, a key-regulator of cytoskeleton encoded by a tumor-suppressor gene on 3p chromosome, is involved in TNTs formation in bronchial and pleural cells since controlling proper activity of RhoB guanine nucleotide exchange factor, GEF-H1. Indeed, the GEF-H1 inactivation induced by RASSF1A silencing, leads to Rab11 accumulation and subsequent exosome releasing, which in turn contribute to TNTs formation. Finally, we provide evidence involving TNT formation in bronchial carcinogenesis, by reporting that hypoxia or nutriment privation, two almost universal conditions in human cancers, fail to prevent TNTs induced by the oncogenic RASSF1A loss of expression. CONCLUSIONS: This finding suggests for the first time that loss of RASSF1A expression could be a potential biomarker for TNTs formation, such TNTs facilitating intercellular communication favoring multistep progression of bronchial epithelial cells toward overt malignancy.


Asunto(s)
Membrana Celular/metabolismo , Factores de Intercambio de Guanina Nucleótido Rho/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Proteínas de Unión al GTP rab/metabolismo , Actomiosina/metabolismo , Línea Celular , Exosomas/metabolismo , Espacio Extracelular/metabolismo , Técnicas de Silenciamiento del Gen , Silenciador del Gen , Humanos , Proteínas Supresoras de Tumor/deficiencia , Proteínas Supresoras de Tumor/genética , Vimentina/metabolismo
3.
Ann Pathol ; 38(3): 198-201, 2018 Jun.
Artículo en Francés | MEDLINE | ID: mdl-29622469

RESUMEN

We report a case of microcystic adnexal carcinoma in a 80-year-old woman. This is a rare malignant adnexal cutaneous tumor with glandular and follicular differentiation, rare, often asymptomatic, with late diagnosis and slow growth, locally aggressive and rarely metastatic. The distinction with other benign and malignant skin tumors is difficult.


Asunto(s)
Carcinoma de Apéndice Cutáneo/patología , Neoplasias de los Labios/patología , Anciano de 80 o más Años , Carcinoma de Apéndice Cutáneo/diagnóstico , Carcinoma de Apéndice Cutáneo/cirugía , Diagnóstico Diferencial , Femenino , Humanos , Neoplasias de los Labios/diagnóstico , Neoplasias de los Labios/cirugía , Reoperación
4.
Ann Pathol ; 36(4): 282-5, 2016 Aug.
Artículo en Francés | MEDLINE | ID: mdl-27475006

RESUMEN

We report a case of vaginal adenosis in a woman of 42years. This is a rare congenital disorder since cessation of use of diethylstilbestrol (DES), usually of benign course, not to ignore in its tubo-endometrial histological form which may progress to atypical adenosis precursor of vaginal clear cell adenocarcinoma in patients exposed in utero to DES.


Asunto(s)
Glándulas Exocrinas/patología , Enfermedades Vaginales/diagnóstico , Adulto , Biopsia , Diferenciación Celular , Diagnóstico Diferencial , Dietilestilbestrol/efectos adversos , Femenino , Humanos , Infertilidad Femenina/etiología , Leiomiomatosis/complicaciones , Pólipos/diagnóstico , Neoplasias Uterinas/complicaciones , Enfermedades Vaginales/patología
6.
Biomed Res Int ; 2020: 2701345, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32351987

RESUMEN

By allowing insured communication between cancer cells themselves and with the neighboring stromal cells, tunneling nanotubes (TNTs) are involved in the multistep process of cancer development from tumorigenesis to the treatment resistance. However, despite their critical role in the biology of cancer, the study of the TNTs has been announced challenging due to not only the absence of a specific biomarker but also the fragile and transitory nature of their structure and the fact that they are hovering freely above the substratum. Here, we proposed to review guidelines to follow for studying the structure and functionality of TNTs in tumoral neuroendocrine cells (PC12) and nontumorigenic human bronchial epithelial cells (HBEC-3, H28). In particular, we reported how crucial is it (i) to consider the culture conditions (culture surface, cell density), (ii) to visualize the formation of TNTs in living cells (mechanisms of formation, 3D representation), and (iii) to identify the cytoskeleton components and the associated elements (categories, origin, tip, and formation/transport) in the TNTs. We also focused on the input of high-resolution cell imaging approaches including Stimulated Emission Depletion (STED) nanoscopy, Transmitted and Scanning Electron Microscopies (TEM and SEM). In addition, we underlined the important role of the organelles in the mechanisms of TNT formation and transfer between the cancer cells. Finally, new biological models for the identification of the TNTs between cancer cells and stromal cells (liquid air interface, ex vivo, in vivo) and the clinical considerations will also be discussed.


Asunto(s)
Comunicación Celular , Tomografía con Microscopio Electrónico , Microscopía Electrónica de Rastreo , Microtúbulos , Neoplasias , Animales , Humanos , Microtúbulos/metabolismo , Microtúbulos/ultraestructura , Neoplasias/metabolismo , Neoplasias/ultraestructura , Células PC12 , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA